newsfilter
← Latest News
PR Newswire·

Fusion Pharmaceuticals to Present at Upcoming March Investor Conferences

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision ...